Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-25 @ 4:17 AM
NCT ID:
NCT04373720
Eligibility Criteria:
Inclusion Criteria
* \>/=18 years old.
* History of a pathology proven intracranial glioma (including IDH mutant, IDH wildtype or 1p19q co-deleted tumors) treated with chemotherapy and radiation.
* The lesion of concern (T2 Flair Hyperintense or contrast enhancing lesion) is \> 2 cm
* Patient is able to understand and give consent to participation in the study.
Exclusion Criteria
* Patients less than 18 years of age.
* Pregnant.
* Known allergy to gadolinium-based contrast agents.
* Renal failure as evidenced by a glomerular filtration rate (GFR) of less than 30 mL/min/1.73m2.
* Pacemakers, electronic stimulation, metallic foreign bodies and devices and/or other conditions that are not MR safe, which include but are not limited to:
* electronically, magnetically, and mechanically activated implants
* ferromagnetic or electronically operated active devices like automatic cardioverter defibrillators and cardiac pacemakers
* metallic splinters in the eye
* ferromagnetic hemostatic clips in the central nervous system (CNS) or body
* cochlear implants
* other pacemakers, e.g., for the carotid sinus
* insulin pumps and nerve stimulators
* non-MR safe lead wires
* prosthetic heart valves (if dehiscence is suspected)
* non-ferromagnetic stapedial implants
* claustrophobia that does not readily respond to oral medication
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04373720
Study Brief:
Protocol Section:
NCT04373720